For help on how to get the results you want, see our search tips.
7 results
Medicine type
Orphan medicine Remove Orphan medicine filter
Biosimilar Remove Biosimilar filter
Additional monitoring Remove Additional monitoring filter
Conditional approval Remove Conditional approval filter
Opinion status
Positive Remove Positive filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Nexviadyme
Avalglucosidase alfa, opinion date: 23/07/2021, Positive, Last updated: 02/08/2021 -
List item
Summary of opinion: Lextemy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Brukinsa
zanubrutinib, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Libmyris
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Hukyndra
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lonapegsomatropin Ascendis Pharma (new)
lonapegsomatropin, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021